Compare Citius Pharmaceuticals Inc (CTXR) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $18.73M), while Vipshop Holdings Ltd - ADR trades at $15.06 (market cap $7.40B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 395.1× Citius Pharmaceuticals Inc's market cap, and Vipshop Holdings Ltd - ADR pays a 4.02% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | VIPS | |
|---|---|---|
Market Cap | $18.73M | $7.40B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $20.68 |
52-Week Low | $0.48 | $12.92 |
Enterprise Value | $14.95M | $3.97B |
Dividend Yield | — | 4.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTXR is trading at $0.68, up 6.28% today, with a bullish technical signal from moving averages. The company shows strong commercial momentum with LYMPHIR cancer treatment revenue reaching $5.6 million in H1 2026, though it remains unprofitable with a -823% net margin. Analyst consensus is strongly bullish with 83% buy ratings.
The outlook depends on LYMPHIR's commercial success offsetting deep losses. Near-term catalysts include expanded market access and combination therapy data, but high cash burn and execution risks require monitoring. The stock offers speculative growth potential in oncology but carries significant financial risk.
Vipshop Holdings (VIPS) trades at $15.68, up 1.75% with a bullish technical signal. The stock shows attractive valuation metrics including a P/E of 7.1 and P/S of 0.5, while maintaining solid profitability with 7.07% net margin and 18.43% ROE. Recent Q1 2026 earnings met expectations, and the company is pursuing growth through outlet store strategies. Analyst consensus leans bullish with 53.57% buy ratings.
The outlook remains constructive given discounted valuation and operational efficiency, though revenue stagnation and competitive pressures in China's e-commerce sector present challenges. Positive cash flow generation and strategic initiatives support potential upside, but investors should monitor execution on growth initiatives amid economic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
